In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 6, 2003, Pages 1025-1028

  Lu, Tao ^a   Drlica, Karl ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Ethambutol; Gatifloxacin; Moxifloxacin; Rifampicin

Indexed keywords

CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; FERUMOXSIL; GATIFLOXACIN; ISONIAZID; MESYLIC ACID ETHYL ESTER; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGAR MEDIUM; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IN VITRO STUDY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; CAPREOMYCIN SULFATE; CYCLOSERINE; DRUG COMBINATIONS; ETHAMBUTOL; FLUOROQUINOLONES; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

EID: 0347519285     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg480     Document Type: Article

References (10)

1. Dong, Y., Xu, C., Zhao, X. et al. (1998). Fluoroquinolone action against mycobacteria: effects of C8 substituents on bacterial growth, survival, and resistance. Antimicrobial Agents and Chemotherapy 42, 2978-84.
2. Dong, Y., Zhao, X., Domagala, J. et al. (1999). Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 43, 1756-8.
3. Zhao, B.-Y., Pine, R., Domagala, J. et al. (1999). Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C8-methoxyl group on survival in liquid media and in human macrophages. Antimicrobial Agents and Chemotherapy 43, 661-6.
4. Dong, Y., Zhao, X., Kreiswirth, B. et al. (2000). Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 44, 2581-4.
5. Alvirez-Freites, E., Carter, J. & Cynamon, M. (2002). In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis. Anti-microbial Agents and Chemotherapy 46, 1022-5.
6. Lounis, N., Bentoucha, A., Truffot-Pernot, C. et al. (2001). Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice. Antimicrobial Agents and Chemotherapy 45, 3482-6.
7. Rastogi, N., Goh, K, Bryskier, A. et al. (1996). In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculosis drugs against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 40, 1610-16.
8. Tomioka, H., Sato, K., Shimizu, T. et al. (2002). Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculosis drugs. Journal of Infection 44, 160-5.
9. Fattorini, L., Tan, D., Iona, E. et al. (2003). Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. Antimicrobial Agents and Chemotherapy 47, 360-2.
10. Kaur, D. & Khuller, G. (2001). In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria. International Journal of Antimicrobial Agents 17, 51-5.